Fig. 4
From: Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands
GPCRs (a) and endogenous peptidergic ligands (b) and the highest stage in global pharma pipeline. In each panel, the leftmost chart shows the distribution of highest stage (post-clinical, clinical trial, pre-clinical, none) by target type while the other two charts show such distribution among the gene-disease pairs within the Open Targets platform stratified by corresponding overall score (< 0.5, middle; ≥0.5 right)